If the video doesn't load in your browser, open it on YouTube.
Maddie's Story: The Spark Behind the Revolution
When CEO Gavenraj Sodhi's daughter Maddie was diagnosed with autism, epilepsy, and rare genetic conditions, he set out to build a system that could do what traditional medicine couldn’t. Our AI platform pinpointed a repurposed drug that helped Maddie’s autism and fully resolved her seizures — now covered by insurance. That same technology is powering hope for millions.
How It Works
Ask Maddie AI
Interactive AI assistant for patients and clinicians—contextualized by clinical history, genetics, and literature.
Organoid Modeling
Patient-derived iPSCs and 3D organoid models predict therapy responses before prescription.
AI Drug Screening
Cloud AI ranks thousands of compounds to deliver precise, cost-effective treatments.
Roadmap
Generation v1 — Engineered Platform
Current raise: $5M
- Unified patient data (genetics, EHR, symptoms)
- “Ask Maddie” AI Q&A & education
- Patient‑specific iPSC / organoid models
- Cloud AI screens thousands of compounds
- Ranked, actionable therapy recommendations
- Modular, scalable cloud architecture (ROI‑driven)
- Provisional patent submitted
Generation v2 — Biological Computer
Future raise: $100M
- Fully automated sample‑to‑organoid pipeline
- Embedded AI across genomics, imaging & clinical data
- High‑throughput screens with AI‑ranked candidates
- Clinician‑ready therapy match reports
- Single secure cloud platform replaces legacy workflows
- Weeks from intake to treatment proposal; continuous model improvement
Meet the Team
- Gavenraj Sodhi — CEO, Innovator, Father.
- Roger Stepper — Lead Architect, Software Engineer, Maker
- Dr. Taran Gujral — Scientific Director, Fred Hutch & TRACER.
- Dr. Alysson Muotri — UCSD; Organoid Pioneer.
- Michael Bennett — CFO, Pharma, Finance expert.
Our Partners & Supporters
We collaborate with institutions including Houston Methodist, Fred Hutchinson Cancer Center, UCSD, and Baylor College of Medicine.
